Skip to content

Clinical Study Evaluating Safety of a New Catheter for Urinary Intermittent Catheter in Healthy Volunteers

Clinical Study Evaluating Safety of a New Catheter for Urinary Intermittent Catheter in Healthy Volunteers

Status
Withdrawn
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01292941
Enrollment
0
Registered
2011-02-10
Start date
2011-03-31
Completion date
2011-06-30
Last updated
2015-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Brief summary

To evaluate discomfort of a new coating and catheter material compared to SpeediCath (SC)

Detailed description

Intermittent catheterization is the preferred method for emptying the bladder in patients with spinal cord injury and neurogenic bladder dysfunction. Coloplast have developed a new intermittent catheters. In this investigation this new test catheter will be compared with SpeediCat by assessing discomfort and pain associated with catheterization of healthy men. The reason for choosing healthy men is that many catheter users do not have full feeling in their urethra and therefore can not assess the discomfort. 55 healthy men who are ≥ 18 years and have no signs of urinary tract infection and do not have abnormalities, disease or have had operational interventions in the urinary tract will be included. They are recruited through advertisements on the website www.forsoegsperson.dk.

Interventions

DEVICEIntermittent catheterisation

Speedicath, Intermittent catheterisation

DEVICENonCE marked intermittent catheter/red

Paris, Intermittent catheterisation

DEVICENonCE marked intermittent catheter/green

Paris, Intermittent catheter

DEVICENonCE marked intermittent catheter/blue

Paris, Intermittent catheter

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* • ≥18 years * Male * Signed informed consent * Negative urine stix (erythrocytes, leucocytes and nitrite)

Exclusion criteria

* • Abnormalities, diseases or surgical procedures performed in the lower urinary tract

Design outcomes

Primary

MeasureTime frameDescription
Discomfort during catheterisation measured by VAS-scale (0-10)10 measurements in an 11 week period. 10 min after each catheterisationA subject is assesing a VAS scale after each catheterisation.

Secondary

MeasureTime frameDescription
SafetyDuring the investigation 11 Weeks per subjectSafety is evalueted continues while the subjects are testing the devices
Discomfort during urination post catheterisation10 measurements in an 11 week period. 10 min after each catheterisationSubjects own assesment. Yes or no can be answered to discomfort during urination post catheterisation
Haematuria10 measurements in an 11 week period. 10 min after each catheterisationUrine test after each catheterisation, and measured on a urine stix
Handling during insertion, withdrawal10 measurements in an 11 week period. 10 min after each catheterisationEase of use assessed by nurses, measured on a 5 point scale

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026